Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Willow is a women's healthcare company that develops pumping bras and breast pumps for women.
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.
Cue is a healthcare technology company that enables people to manage their health through actionable and connected health data.
AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors.
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.
Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.
Sermonix Pharmaceuticals is an Ohio LLC specialty pharmaceutical.
Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.
Zentera Therapeutics is a biopharmaceutical company.
Motus GI touted clinical data evaluating its Pure-Vu cleaning system.
NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.
Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine.
Renovia was a developer of prescription digital therapeutics for pelvic floor disorders. Renovia ceased operations in late 2022.
Graphite Bio is a next-generation gene editing company that is driven to apply our breakthrough technology.
LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
Zymergen is a biotechnology company that specializes in machine learning, big data, and artificial intelligence.
Rain Oncology is a operator of a clinical stage biotechnology company.
Perceptive Advisors has invested in 225 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Medical. The firm invests across 31 different industry categories.
Among tracked funding rounds, Blueprint Medicines received $1.3B in a Post Ipo Equity round. Perceptive Advisors's total known invested capital is $29.6B.
Perceptive Advisors's average investment size is $156.7M across its portfolio of 225 companies.
Recent Perceptive Advisors portfolio additions include Willow, RayzeBio, Point Biopharma, CinCor Pharma, Achilles Therapeutics. These companies were founded in 2020 or later.